Canada medical cannabis market has been steadily growing. The country has seen an average of a 10 percent increase each month in the number of Canadian patients signed up to receive medical cannabis. The sale of dried cannabis has grown steadily at 6 percent a month, and the sale of cannabis oil has been growing by 16 percent a month.

As of October, 2018, Health Canada has issued 132 licenses to LPs, including 125 licences for cultivation and 72 licenses for oil production. Canopy Growth holds seven separate licenses, Aurora Cannabis Enterprises holds four, Maricann holds three, BC Tweed holds two, Cann Trust holds two, Emerald Health Therapeutics holds two, Bedrocan Canada holds two, RedeCan holds two and MedReleaf holds two.

Currently, there are more than 270,000 Canadians who are registered to purchase medical cannabis from 132 licensed medical cannabis producers in the second quarter of this year. About 110,000 were in Ontario, 104,000 were in Alberta. These Canadians receive their medical cannabis either through the post or through private couriers. Additionally, more than 4,000 Canadians are registered through Health Canada to produce a limited amount of cannabis for their own medical use.

Naturally, the increase in MMJ patients resulted in a significant increase in sales as well. The Canadian medical market exceeded $450 million in sales in 2017, a 105% increase from previous year’s sales.